ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

April 17, 1981

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980